Myelodysplastic syndrome is considered to be a group of diseases, the common characteristic of which is the violation of the function of the bone marrow, which leads to a lack healthy blood cells count. However, this syndrome includes the diseases of the blood and bone marrow.
Normal human bone marrow cells must develop stem in an immature form, after they are converted into mature lymphoid and myeloid cells and. In turn, the formation of lymphoid leukocytes is begun from erythrocytes and platelets - from myeloid cells.
The disease is characterized by a complete lack or a violation of a full-fledged production of immature stem cells. Today the treatment of myelodysplastic syndrome in Israel is considered to be the most effective; in addition it is worth noting that despite the high effectiveness of the cost of medical services in our country it is much lower than in America or Europe.
Treatment of myelodysplastic syndrome in Israel
The primary goal of therapy is to eliminate or alleviate the symptoms of the disease, and at the same time by all means to improve the quality and length of the patient`s life. In most cases, treatment includes supportive therapy which is capable to muffle major symptoms of the disease, and aggressive type of therapy that is designed to retard or prevent the progression of the disease.
However, the only way to treat myelodysplastic syndrome that can lead to full recovery, today is bone marrow transplantation. Now it is possible to perform the bone marrow transplantation from a related donor or an unrelated or from the patient's.
Most often the disease may be accompanied by feeling a strong sense of fatigue and the appearance of persistent infections or viral diseases.
In this case it is possible perform transfusion with blood products or therapy by growth factor.
The use of transfusion therapy
This method is often used in the treatment of myelodysplastic syndrome in Israel. Its essence lies in the transfusion of platelets, white blood cells and red blood cells for replacement of the affected cells by disease. In some cases it may promote the increase of the iron content in the blood. Because of this, together with this method of therapy is used concomitant therapy, the purpose of which is removal of excess iron from the body.
The use of chemotherapy in treatment of myelodysplastic syndrome in Israel
In certain cases, specialists need to use chemotherapy to stop the progression of the disease process and reduce the need for uninterrupted cycle of application transfusion. Treatment of myelodysplastic syndrome involves the use of chemotherapy before the procedure of the donor stem cell transplantation. This step is essential to ensure that the cells survived, and the operation itself was successful.
In the treatment of myelodysplastic syndrome in Israel are used potent chemotherapeutic medications that are aimed at suppressing the growth of immature cells, destruction of already formed cancer cells and preventing their separation and distribution in the tissue of other organs.
The main aim of these medicaments is still getting into the bloodstream and destroying cancer cells by inhibiting the process of their distribution throughout the body. Sometimes it is a necessary step of intrathecal therapy, during which the drug is injected directly into the spinal column. The use of a particular method depends on the development of cancer.